Detection of Neutralizing Antibody Against SARS-CoV-2 in RT-PCR Confirmed COVID-19 Patient with Diverse Disease Severity
- Conditions
- COVID-19
- Registration Number
- TCTR20210329003
- Lead Sponsor
- King Chulalongkorn Memorial Hospital Excellence Center Program,
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending (Not yet recruiting)
- Sex
- All
- Target Recruitment
- 36
Inclusion Criteria
RT-PCR positive confirmed COVID-19 patient admitted in King Chulalongkorn Memorial Hospital from February 2020 to May 2020
Exclusion Criteria
Patient who loss follow up
Patient who denied from the study
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method %inhibition at the time COVID-19 diagnosed by RT-PCR The study aims to measure the %inhibition of neutralizing antibody measure by surrogate virus neutralization test (sVNT) (cPassTM, GenScript, USA) in RT-PCR confirmed COVID-19 patients.
- Secondary Outcome Measures
Name Time Method %inhibition 3, 6, 9, 12 months after diagnosis unpaired t-test